Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RAD51D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC7A6OS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC374443 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
GNB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AKR7A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAQR4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCED1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UTP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC29A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMED4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AJUBA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RARRES3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STAG3L2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DDX19A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NFATC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEBPB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APLP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FOXP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACTR1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CENPA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on